Global COVID-19 Molecular Diagnostics Market Size, Status and Forecast 2020-2026

July 2020 | 151 pages | ID: GC4EE9F52704EN
QYResearch

Abstracts

This report focuses on the global COVID-19 Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Molecular Diagnostics development in North America, Europe, China and Japan.
The key players covered in this study

• Cellex
• Abbott
• Roche
• BioMedomics
• BD
• Henry Schein
• Safecare Bio-Tech
• Thermo Fisher
• Bio-rad
• Agilent
• Ortho Clinical Diagnostics
• Zhejiang Orient Gene Biotech
• Innovita Biological Technology
• Guangzhou Wondfo Biotech
• Guangdong Hecin-Scientific
• Dynamiker Biotechnology (Tianjin)
• ADVAITE
• Mayo Clinic Laboratories
• Chembio Diagnostics
• Mount Sinai Laboratory
• QIAGEN
• Bioer
• Biosynex
• Esco
• Analytik Jena
• Techne
• Da An Gene
• BGI
• Shanghai ZJ Bio-Tech

Market segment by Type, the product can be split into

• High-throughput Sequencing
• Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
• Immunological Detection

Market segment by Application, split into

• Hospitals
• Scientific Research
• Biodiagnostics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global COVID-19 Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the COVID-19 Molecular Diagnostics development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 Molecular Diagnostics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 Molecular Diagnostics Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 High-throughput Sequencing
  1.4.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
  1.4.4 Immunological Detection
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global COVID-19 Molecular Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Scientific Research
  1.5.4 Biodiagnostics
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 Molecular Diagnostics Industry Impact
  1.6.1 How the Covid-19 is Affecting the COVID-19 Molecular Diagnostics Industry
    1.6.1.1 COVID-19 Molecular Diagnostics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and COVID-19 Molecular Diagnostics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for COVID-19 Molecular Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Covid-19 Implications on Global COVID-19 Molecular Diagnostics Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global COVID-19 Molecular Diagnostics Growth Trends by Regions
  2.2.1 COVID-19 Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 COVID-19 Molecular Diagnostics Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 COVID-19 Molecular Diagnostics Revenue by Players (2019-2020)
3.2 COVID-19 Molecular Diagnostics Key Players Head office and Area Served
3.3 Key Players COVID-19 Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 Molecular Diagnostics Market
3.5 Key Players COVID-19 Molecular Diagnostics Funding/Investment Analysis
3.6 Global Key Players COVID-19 Molecular Diagnostics Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 GLOBAL COVID-19 MOLECULAR DIAGNOSTICS MARKET SIZE BY TYPE (2019-2026)

5 GLOBAL COVID-19 MOLECULAR DIAGNOSTICS MARKET SIZE BY APPLICATION (2019-2026)

6 NORTH AMERICA

6.1 North America COVID-19 Molecular Diagnostics Market Forecast (2019-2026)
6.2 COVID-19 Molecular Diagnostics Key Players in North America (2019-2020)
6.3 North America COVID-19 Molecular Diagnostics Market Size by Type (2015-2020)
6.4 North America COVID-19 Molecular Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe COVID-19 Molecular Diagnostics Market Forecast (2019-2026)
7.2 COVID-19 Molecular Diagnostics Key Players in Europe (2019-2020)
7.3 Europe COVID-19 Molecular Diagnostics Market Size by Type (2015-2020)
7.4 Europe COVID-19 Molecular Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China COVID-19 Molecular Diagnostics Market Forecast (2019-2026)
8.2 COVID-19 Molecular Diagnostics Key Players in China (2019-2020)
8.3 China COVID-19 Molecular Diagnostics Market Size by Type (2015-2020)
8.4 China COVID-19 Molecular Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan COVID-19 Molecular Diagnostics Market Forecast (2019-2026)
9.2 COVID-19 Molecular Diagnostics Key Players in Japan (2019-2020)
9.3 Japan COVID-19 Molecular Diagnostics Market Size by Type (2015-2020)
9.4 Japan COVID-19 Molecular Diagnostics Market Size by Application (2015-2020)

10KEY PLAYERS PROFILES

10.1 Cellex
  10.1.1 Cellex Company Details
  10.1.2 Cellex Business Overview and Its Total Revenue
  10.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
  10.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.1.5 Cellex Recent Development
10.2 Abbott
  10.2.1 Abbott Company Details
  10.2.2 Abbott Business Overview and Its Total Revenue
  10.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
  10.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.2.5 Abbott Recent Development
10.3 Roche
  10.3.1 Roche Company Details
  10.3.2 Roche Business Overview and Its Total Revenue
  10.3.3 Roche COVID-19 Molecular Diagnostics Introduction
  10.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.3.5 Roche Recent Development
10.4 BioMedomics
  10.4.1 BioMedomics Company Details
  10.4.2 BioMedomics Business Overview and Its Total Revenue
  10.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
  10.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.4.5 BioMedomics Recent Development
10.5 BD
  10.5.1 BD Company Details
  10.5.2 BD Business Overview and Its Total Revenue
  10.5.3 BD COVID-19 Molecular Diagnostics Introduction
  10.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.5.5 BD Recent Development
10.6 Henry Schein
  10.6.1 Henry Schein Company Details
  10.6.2 Henry Schein Business Overview and Its Total Revenue
  10.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
  10.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.6.5 Henry Schein Recent Development
10.7 Safecare Bio-Tech
  10.7.1 Safecare Bio-Tech Company Details
  10.7.2 Safecare Bio-Tech Business Overview and Its Total Revenue
  10.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
  10.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.7.5 Safecare Bio-Tech Recent Development
10.8 Thermo Fisher
  10.8.1 Thermo Fisher Company Details
  10.8.2 Thermo Fisher Business Overview and Its Total Revenue
  10.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
  10.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.8.5 Thermo Fisher Recent Development
10.9 Bio-rad
  10.9.1 Bio-rad Company Details
  10.9.2 Bio-rad Business Overview and Its Total Revenue
  10.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
  10.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.9.5 Bio-rad Recent Development
10.10 Agilent
  10.10.1 Agilent Company Details
  10.10.2 Agilent Business Overview and Its Total Revenue
  10.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
  10.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.10.5 Agilent Recent Development
10.11 Ortho Clinical Diagnostics
  10.11.1 Ortho Clinical Diagnostics Company Details
  10.11.2 Ortho Clinical Diagnostics Business Overview and Its Total Revenue
  10.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
  10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.11.5 Ortho Clinical Diagnostics Recent Development
10.12 Zhejiang Orient Gene Biotech
  10.12.1 Zhejiang Orient Gene Biotech Company Details
  10.12.2 Zhejiang Orient Gene Biotech Business Overview and Its Total Revenue
  10.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
  10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.12.5 Zhejiang Orient Gene Biotech Recent Development
10.13 Innovita Biological Technology
  10.13.1 Innovita Biological Technology Company Details
  10.13.2 Innovita Biological Technology Business Overview and Its Total Revenue
  10.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
  10.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.13.5 Innovita Biological Technology Recent Development
10.14 Guangzhou Wondfo Biotech
  10.14.1 Guangzhou Wondfo Biotech Company Details
  10.14.2 Guangzhou Wondfo Biotech Business Overview and Its Total Revenue
  10.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
  10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.14.5 Guangzhou Wondfo Biotech Recent Development
10.15 Guangdong Hecin-Scientific
  10.15.1 Guangdong Hecin-Scientific Company Details
  10.15.2 Guangdong Hecin-Scientific Business Overview and Its Total Revenue
  10.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
  10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.15.5 Guangdong Hecin-Scientific Recent Development
10.16 Dynamiker Biotechnology (Tianjin)
  10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
  10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview and Its Total Revenue
  10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
  10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
10.17 ADVAITE
  10.17.1 ADVAITE Company Details
  10.17.2 ADVAITE Business Overview and Its Total Revenue
  10.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
  10.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.17.5 ADVAITE Recent Development
10.18 Mayo Clinic Laboratories
  10.18.1 Mayo Clinic Laboratories Company Details
  10.18.2 Mayo Clinic Laboratories Business Overview and Its Total Revenue
  10.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
  10.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.18.5 Mayo Clinic Laboratories Recent Development
10.19 Chembio Diagnostics
  10.19.1 Chembio Diagnostics Company Details
  10.19.2 Chembio Diagnostics Business Overview and Its Total Revenue
  10.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
  10.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.19.5 Chembio Diagnostics Recent Development
10.20 Mount Sinai Laboratory
  10.20.1 Mount Sinai Laboratory Company Details
  10.20.2 Mount Sinai Laboratory Business Overview and Its Total Revenue
  10.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
  10.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.20.5 Mount Sinai Laboratory Recent Development
10.21 QIAGEN
  10.21.1 QIAGEN Company Details
  10.21.2 QIAGEN Business Overview and Its Total Revenue
  10.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
  10.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.21.5 QIAGEN Recent Development
10.22 Bioer
  10.22.1 Bioer Company Details
  10.22.2 Bioer Business Overview and Its Total Revenue
  10.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
  10.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.22.5 Bioer Recent Development
10.23 Biosynex
  10.23.1 Biosynex Company Details
  10.23.2 Biosynex Business Overview and Its Total Revenue
  10.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
  10.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.23.5 Biosynex Recent Development
10.24 Esco
  10.24.1 Esco Company Details
  10.24.2 Esco Business Overview and Its Total Revenue
  10.24.3 Esco COVID-19 Molecular Diagnostics Introduction
  10.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.24.5 Esco Recent Development
10.25 Analytik Jena
  10.25.1 Analytik Jena Company Details
  10.25.2 Analytik Jena Business Overview and Its Total Revenue
  10.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
  10.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.25.5 Analytik Jena Recent Development
10.26 Techne
  10.26.1 Techne Company Details
  10.26.2 Techne Business Overview and Its Total Revenue
  10.26.3 Techne COVID-19 Molecular Diagnostics Introduction
  10.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.26.5 Techne Recent Development
10.27 Da An Gene
  10.27.1 Da An Gene Company Details
  10.27.2 Da An Gene Business Overview and Its Total Revenue
  10.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
  10.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.27.5 Da An Gene Recent Development
10.28 BGI
  10.28.1 BGI Company Details
  10.28.2 BGI Business Overview and Its Total Revenue
  10.28.3 BGI COVID-19 Molecular Diagnostics Introduction
  10.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.28.5 BGI Recent Development
10.29 Shanghai ZJ Bio-Tech
  10.29.1 Shanghai ZJ Bio-Tech Company Details
  10.29.2 Shanghai ZJ Bio-Tech Business Overview and Its Total Revenue
  10.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
  10.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2020))
  10.29.5 Shanghai ZJ Bio-Tech Recent Development

11 MARKET DYNAMICS

11.1 Drivers
11.2 Challenges
11.3 Porter’s Five Forces Analysis
11.4 Market Ecosystem and Value Chain Analysis

12 KEY FINDINGS IN THIS REPORT

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Molecular Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 Molecular Diagnostics Revenue
Table 3. Ranking of Global Top COVID-19 Molecular Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of High-throughput Sequencing
Table 6. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 7. Key Players of Immunological Detection
Table 8. COVID-19 Impact Global Market: (Four COVID-19 Molecular Diagnostics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for COVID-19 Molecular Diagnostics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for COVID-19 Molecular Diagnostics Players to Combat Covid-19 Impact
Table 13. Global COVID-19 Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 Molecular Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 Molecular Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global COVID-19 Molecular Diagnostics Market Share by Regions 2019-2026
Table 17. Market Top Trends
Table 18. Market Use Cases
Table 19. Global COVID-19 Molecular Diagnostics Revenue by Players (2019-2020) (Million US$)
Table 20. Global COVID-19 Molecular Diagnostics Market Share by Players (2019-2020)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players COVID-19 Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into COVID-19 Molecular Diagnostics Market
Table 24. Global Key Players COVID-19 Molecular Diagnostics Funding/Investment Analysis (Million USD)
Table 25. Global Key Players COVID-19 Molecular Diagnostics Valuation & Market Capitalization (Million USD)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global COVID-19 Molecular Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 28. Global COVID-19 Molecular Diagnostics Market Size Share by Type (2019-2026)
Table 29. Global COVID-19 Molecular Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 30. Global COVID-19 Molecular Diagnostics Market Size Share by Application (2019-2026)
Table 31. North America Key Players COVID-19 Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 32. North America Key Players COVID-19 Molecular Diagnostics Market Share (2019-2020)
Table 33. North America COVID-19 Molecular Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 34. North America COVID-19 Molecular Diagnostics Market Share by Type (2019-2026)
Table 35. North America COVID-19 Molecular Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 36. North America COVID-19 Molecular Diagnostics Market Share by Application (2019-2026)
Table 37. Europe Key Players COVID-19 Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 38. Europe Key Players COVID-19 Molecular Diagnostics Market Share (2019-2020)
Table 39. Europe COVID-19 Molecular Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 40. Europe COVID-19 Molecular Diagnostics Market Share by Type (2019-2026)
Table 41. Europe COVID-19 Molecular Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 42. Europe COVID-19 Molecular Diagnostics Market Share by Application (2019-2026)
Table 43. China Key Players COVID-19 Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 44. China Key Players COVID-19 Molecular Diagnostics Market Share (2019-2020)
Table 45. China COVID-19 Molecular Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 46. China COVID-19 Molecular Diagnostics Market Share by Type (2019-2026)
Table 47. China COVID-19 Molecular Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 48. China COVID-19 Molecular Diagnostics Market Share by Application (2019-2026)
Table 49. Japan Key Players COVID-19 Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 50. Japan Key Players COVID-19 Molecular Diagnostics Market Share (2019-2020)
Table 51. Japan COVID-19 Molecular Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 52. Japan COVID-19 Molecular Diagnostics Market Share by Type (2019-2026)
Table 53. Japan COVID-19 Molecular Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 54. Japan COVID-19 Molecular Diagnostics Market Share by Application (2019-2026)
Table 55. Cellex Company Details
Table 56. Cellex Business Overview
Table 57. Cellex Product
Table 58. Company Description and Business Overview
Table 59. Cellex COVID-19 Molecular Diagnostics Product
Table 60. Cellex Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 61. Cellex Recent Development
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Product
Table 65. Company Description and Business Overview
Table 66. Abbott COVID-19 Molecular Diagnostics Product
Table 67. Abbott Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 68. Abbott Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Product
Table 72. Company Description and Business Overview
Table 73. Roche COVID-19 Molecular Diagnostics Product
Table 74. Roche Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 75. Roche Recent Development
Table 76. BioMedomics Company Details
Table 77. BioMedomics Business Overview
Table 78. BioMedomics Product
Table 79. Company Description and Business Overview
Table 80. BioMedomics COVID-19 Molecular Diagnostics Product
Table 81. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 82. BioMedomics Recent Development
Table 83. BD Company Details
Table 84. BD Business Overview
Table 85. BD Product
Table 86. Company Description and Business Overview
Table 87. BD COVID-19 Molecular Diagnostics Product
Table 88. BD Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 89. BD Recent Development
Table 90. Henry Schein Company Details
Table 91. Henry Schein Business Overview
Table 92. Henry Schein Product
Table 93. Company Description and Business Overview
Table 94. Henry Schein COVID-19 Molecular Diagnostics Product
Table 95. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 96. Henry Schein Recent Development
Table 97. Safecare Bio-Tech Company Details
Table 98. Safecare Bio-Tech Business Overview
Table 99. Safecare Bio-Tech Product
Table 100. Company Description and Business Overview
Table 101. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 102. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 103. Safecare Bio-Tech Recent Development
Table 104. Thermo Fisher Business Overview
Table 105. Thermo Fisher Product
Table 106. Thermo Fisher Company Details
Table 107. Company Description and Business Overview
Table 108. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 109. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 110. Thermo Fisher Recent Development
Table 111. Bio-rad Company Details
Table 112. Bio-rad Business Overview
Table 113. Bio-rad Product
Table 114. Company Description and Business Overview
Table 115. Bio-rad COVID-19 Molecular Diagnostics Product
Table 116. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 117. Bio-rad Recent Development
Table 118. Agilent Company Details
Table 119. Agilent Business Overview
Table 120. Agilent Product
Table 121. Company Description and Business Overview
Table 122. Agilent COVID-19 Molecular Diagnostics Product
Table 123. Agilent Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 124. Agilent Recent Development
Table 125. Ortho Clinical Diagnostics Company Details
Table 126. Ortho Clinical Diagnostics Business Overview
Table 127. Ortho Clinical Diagnostics Product
Table 128. Company Description and Business Overview
Table 129. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 130. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 131. Ortho Clinical Diagnostics Recent Development
Table 132. Zhejiang Orient Gene Biotech Company Details
Table 133. Zhejiang Orient Gene Biotech Business Overview
Table 134. Zhejiang Orient Gene Biotech Product
Table 135. Company Description and Business Overview
Table 136. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 137. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 138. Zhejiang Orient Gene Biotech Recent Development
Table 139. Innovita Biological Technology Company Details
Table 140. Innovita Biological Technology Business Overview
Table 141. Innovita Biological Technology Product
Table 142. Company Description and Business Overview
Table 143. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 144. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 145. Innovita Biological Technology Recent Development
Table 146. Guangzhou Wondfo Biotech Company Details
Table 147. Guangzhou Wondfo Biotech Business Overview
Table 148. Guangzhou Wondfo Biotech Product
Table 149. Company Description and Business Overview
Table 150. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 151. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 152. Guangzhou Wondfo Biotech Recent Development
Table 153. Guangdong Hecin-Scientific Company Details
Table 154. Guangdong Hecin-Scientific Business Overview
Table 155. Guangdong Hecin-Scientific Product
Table 156. Company Description and Business Overview
Table 157. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 158. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 159. Guangdong Hecin-Scientific Recent Development
Table 160. Dynamiker Biotechnology (Tianjin) Company Details
Table 161. Dynamiker Biotechnology (Tianjin) Business Overview
Table 162. Dynamiker Biotechnology (Tianjin) Product
Table 163. Company Description and Business Overview
Table 164. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 165. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 166. Dynamiker Biotechnology (Tianjin) Recent Development
Table 167. ADVAITE Company Details
Table 168. ADVAITE Business Overview
Table 169. ADVAITE Product
Table 170. Company Description and Business Overview
Table 171. ADVAITE COVID-19 Molecular Diagnostics Product
Table 172. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 173. ADVAITE Recent Development
Table 174. Mayo Clinic Laboratories Company Details
Table 175. Mayo Clinic Laboratories Business Overview
Table 176. Mayo Clinic Laboratories Product
Table 177. Company Description and Business Overview
Table 178. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 179. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 180. Mayo Clinic Laboratories Recent Development
Table 181. Chembio Diagnostics Company Details
Table 182. Chembio Diagnostics Business Overview
Table 183. Chembio Diagnostics Product
Table 184. Company Description and Business Overview
Table 185. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 186. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 187. Chembio Diagnostics Recent Development
Table 188. Mount Sinai Laboratory Company Details
Table 189. Mount Sinai Laboratory Business Overview
Table 190. Mount Sinai Laboratory Product
Table 191. Company Description and Business Overview
Table 192. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 193. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 194. Mount Sinai Laboratory Recent Development
Table 195. QIAGEN Company Details
Table 196. QIAGEN Business Overview
Table 197. QIAGEN Product
Table 198. Company Description and Business Overview
Table 199. QIAGEN COVID-19 Molecular Diagnostics Product
Table 200. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 201. QIAGEN Recent Development
Table 202. Bioer Company Details
Table 203. Bioer Business Overview
Table 204. Bioer Product
Table 205. Company Description and Business Overview
Table 206. Bioer COVID-19 Molecular Diagnostics Product
Table 207. Bioer Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 208. Bioer Recent Development
Table 209. Biosynex Company Details
Table 210. Biosynex Business Overview
Table 211. Biosynex Product
Table 212. Company Description and Business Overview
Table 213. Biosynex COVID-19 Molecular Diagnostics Product
Table 214. Biosynex Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 215. Biosynex Recent Development
Table 216. Esco Company Details
Table 217. Esco Business Overview
Table 218. Esco Product
Table 219. Company Description and Business Overview
Table 220. Esco COVID-19 Molecular Diagnostics Product
Table 221. Esco Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 222. Esco Recent Development
Table 223. Analytik Jena Company Details
Table 224. Analytik Jena Business Overview
Table 225. Analytik Jena Product
Table 226. Company Description and Business Overview
Table 227. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 228. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 229. Analytik Jena Recent Development
Table 230. Techne Company Details
Table 231. Techne Business Overview
Table 232. Techne Product
Table 233. Company Description and Business Overview
Table 234. Techne COVID-19 Molecular Diagnostics Product
Table 235. Techne Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 236. Techne Recent Development
Table 237. Da An Gene Company Details
Table 238. Da An Gene Business Overview
Table 239. Da An Gene Product
Table 240. Company Description and Business Overview
Table 241. Da An Gene COVID-19 Molecular Diagnostics Product
Table 242. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 243. Da An Gene Recent Development
Table 244. BGI Company Details
Table 245. BGI Business Overview
Table 246. BGI Product
Table 247. Company Description and Business Overview
Table 248. BGI COVID-19 Molecular Diagnostics Product
Table 249. BGI Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 250. BGI Recent Development
Table 251. Shanghai ZJ Bio-Tech Company Details
Table 252. Shanghai ZJ Bio-Tech Business Overview
Table 253. Shanghai ZJ Bio-Tech Product
Table 254. Company Description and Business Overview
Table 255. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 256. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2019 and 2020 (Million US$)
Table 257. Shanghai ZJ Bio-Tech Recent Development
Table 258. Company Description and Business Overview
Table 259. Company Description and Business Overview
Table 260. Company Description and Business Overview
Table 261. Company Description and Business Overview
Table 262. Company Description and Business Overview
Table 263. Company Description and Business Overview
Table 264. Company Description and Business Overview
Table 265. Company Description and Business Overview
Table 266. Company Description and Business Overview
Table 267. Company Description and Business Overview
Table 268. Company Description and Business Overview
Table 269. Key Drivers: Impact Analysis (2021-2026)
Table 270. Key Opportunities
Table 271. Key Challenges
Table 272. Research Programs/Design for This Report
Table 273. Key Data Information from Secondary Sources
Table 274. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global COVID-19 Molecular Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. High-throughput Sequencing Features
Figure 3. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 4. Immunological Detection Features
Figure 5. Global COVID-19 Molecular Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Scientific Research Case Studies
Figure 8. Biodiagnostics Case Studies
Figure 9. COVID-19 Molecular Diagnostics Report Years Considered
Figure 10. Global COVID-19 Molecular Diagnostics and Growth Rate (2019-2026) (Million US$)
Figure 11. Global COVID-19 Molecular Diagnostics Market Share by Regions (2019-2026)
Figure 12. Global COVID-19 Molecular Diagnostics Market Share by Players in 2019
Figure 13. Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2019-2026)
Figure 14. Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2019-2026)
Figure 15. North America COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. Europe COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. China COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Japan COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Bottom-up and Top-down Approaches for This Report
Figure 20. Data Triangulation
Figure 21. Key Executives Interviewed